Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anand Mehra currently holds 4,793 shares of Aclaris Therapeutics, Inc. (ACRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anand Mehra has been a net seller of ACRS stock. They have purchased $25.6M and sold $169.7M worth of shares.
Anand Mehra's most recent insider trade was on Jun 6, 2024, when they sold 4,793 shares at $0.00 per share.
Anand Mehra serves as Executive at Aclaris Therapeutics, Inc. (ACRS). They have executed 89 insider transactions totaling $195.3M over their tenure at the company.
Anand Mehra holds the position of Executive at Aclaris Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Anand Mehra has shown a selling trading pattern, with $25.6M in total purchases and $169.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Anand Mehra was on Dec 17, 2019, when they sold $55.1M worth of ONCE shares. This transaction involved 481,270 shares at $114.50 per share.
Anand Mehra currently owns 4,793 shares of Aclaris Therapeutics, Inc. (ACRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anand Mehra's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anand Mehra has 89 Form 4 filings on record as an insider at Aclaris Therapeutics, Inc..
Set alerts for Anand Mehra and 40,000+ other insiders.